Increased matriptase zymogen activation in inflammatory skin disorders.

Increased matriptase zymogen activation in inflammatory skin disorders.

Item
http://www.wikidata.org/entity/Q34717980
Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes.HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cellsNatural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner.Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas.Matriptase and prostasin are expressed in human skin in an inverse trend over the course of differentiation and are targeted to different regions of the plasma membrane.Matriptase expression and zymogen activation in human pilosebaceous unit.Matriptase regulates proliferation and early, but not terminal, differentiation of human keratinocytesChanges in the distribution of type II transmembrane serine protease, TMPRSS2 and in paracellular permeability in IPEC-J2 cells exposed to oxidative stress.Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.Increased filaggrin-metabolizing enzyme activity in atopic skin: a pilot study using a canine model of atopic dermatitis.Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.Changing the selectivity profile - from substrate analog inhibitors of thrombin and factor Xa to potent matriptase inhibitors.Activated matriptase as a target to treat breast cancer with a drug conjugate.
P2860

Increased matriptase zymogen activation in inflammatory skin disorders.

Item
http://www.wikidata.org/entity/Q34717980
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased matriptase zymogen activation in inflammatory skin disorders.
@ast
Increased matriptase zymogen activation in inflammatory skin disorders.
@en
Increased matriptase zymogen activation in inflammatory skin disorders.
@nl
type
label
Increased matriptase zymogen activation in inflammatory skin disorders.
@ast
Increased matriptase zymogen activation in inflammatory skin disorders.
@en
Increased matriptase zymogen activation in inflammatory skin disorders.
@nl
prefLabel
Increased matriptase zymogen activation in inflammatory skin disorders.
@ast
Increased matriptase zymogen activation in inflammatory skin disorders.
@en
Increased matriptase zymogen activation in inflammatory skin disorders.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Increased matriptase zymogen activation in inflammatory skin disorders.
@en
P2093
P2860
P304
P31
P356
10.1152/AJPCELL.00403.2010
P433
P478
P577
P5875
P698
P921
P932